Mental Health Clinics in Big Bear Lake, CA Accepting Medicare
7 Mental Health Clinics found. Showing 1 - 7
 Lutheran Social Services Of Southern California Counselor - Mental Health Medicare: Not Enrolled in Medicare Practice Location: 41945 Big Bear Blvd Ste 222, Big Bear Lake, CA 92315 Phone: 909-866-5070 Fax: 909-878-3228 |
Lutheran Social Services Community/Behavioral Health Agency Medicare: Not Enrolled in Medicare Practice Location: 41945 Big Bear Blvd. Suite 200,222, Big Bear Lake, CA 92315 Phone: 909-866-5070 |
Desert/mountain Children's Center Community/Behavioral Health Agency Medicare: Not Enrolled in Medicare Practice Location: 42007 Fox Farm Road, Suite 2a, Big Bear Lake, CA 92315 Phone: 760-242-6336 |
Operation Breakthrough Community/Behavioral Health Agency Medicare: Not Enrolled in Medicare Practice Location: 40880 Pedder Rd, Big Bear Lake, CA 92315 Phone: 909-866-5437 Fax: 909-866-8555 |
Lutheran Social Services Counselor - Mental Health Medicare: Not Enrolled in Medicare Practice Location: 41945 Big Bear Blvd, Suites 221, 222,223, Big Bear Lake, CA 92315 Phone: 909-866-5070 Fax: 909-878-3228 |
Atomic Shrink Psychology, Inc Psychologist - Clinical Medicare: Medicare Enrolled Practice Location: 40585 Big Bear Blvd, Suite 2, Big Bear Lake, CA 92315 Phone: 909-255-5351 Fax: 800-976-0803 |
Lutheran Social Services Community/Behavioral Health Agency Medicare: Not Enrolled in Medicare Practice Location: 41945 Big Bear Blvd, Suites 221,222,223, Big Bear Lake, CA 92315 Phone: 909-866-5070 |
News Archive
Hyperbaric oxygen therapy can enhance the cognitive performance of healthy older adults
The Sagol Center for Hyperbaric Medicine and Research at Shamir Medical Center, together with the Sackler School of Medicine and Sagol School of Neuroscience at Tel Aviv University, announced today that a peer-reviewed study has demonstrated for the first time that hyperbaric oxygen therapy (HBOT) can significantly enhance the cognitive performance of healthy older adults.
Dosing initiated in combination Phase I study of palifosfamide with etoposide and cisplatin/carboplatin in SCLC
ZIOPHARM Oncology, Inc., announced today that the first patient has been dosed in a Phase I, single arm, dose escalation study at the Indiana University Cancer Center of intravenous (IV) palifosfamide (ZIO-201) in combination with etoposide (VP-16) and cisplatin/carboplatin (platinum) in the treatment of small cell lung cancer (SCLC) and other cancers.
Discovery sheds light on how the Hippo pathway maintains cellular balance
Researchers at University of California, San Diego School of Medicine have discovered a self-regulating loop in the Hippo pathway, a signaling channel garnering increased attention from cancer researchers due to its role in controlling organ size, cell proliferation and cell death.
Scientists uncover new layer of information in the genetic code
A hidden and never before recognized layer of information in the genetic code has been uncovered by a team of scientists at the University of California, San Francisco (UCSF) thanks to a technique developed at UCSF called ribosome profiling, which enables the measurement of gene activity inside living cells - including the speed with which proteins are made.
› Verified 8 days ago